Jupiter Neurosciences

Jupiter Neurosciences ROE

The Return on Equity (ROE) of Jupiter Neurosciences (JUNS) as of Oct 18, 2026 is 471.92 %. In the previous year, Return on Equity (ROE) was -58.48 % — a change of -907.03% (higher).

ROE

471.92 %

YoY

-907.03%

Last updated:

In 2025, Jupiter Neurosciences's return on equity (ROE) was 471.92 %, a -907.03% increase from the -58.48 % ROE in the previous year.

The Jupiter Neurosciences ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
60.74 USD
Jan 1, 2020
44.59 USD
Jan 1, 2021
84.58 USD
Jan 1, 2022
69.39 USD
Jan 1, 2023
82.46 USD
Jan 1, 2024
-58.48 USD
Jan 1, 2025
471.92 USD
The Jupiter Neurosciences ROE history
YEARROEYoY
471.92 %-907.03%
-58.48 %-170.92%
82.46 %+18.83%
69.39 %-17.96%
84.58 %+89.69%
44.59 %-26.59%
60.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jupiter Neurosciences Stock analysis

What does Jupiter Neurosciences do? Jupiter Neurosciences Inc, based in Palm Beach Gardens, Florida, is a clinical-stage pharmaceutical company focused on developing treatments for neuro-inflammation. The company, with four employees, has developed JOTROL, a micellar resveratrol formulation targeting rare diseases such as Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and MELAS, as well as broader conditions like Parkinson's Disease and early Alzheimer’s. JOTROL, delivered in 100mg soft gel capsules, is licensed globally from Aquanova AG for development and distribution. Jupiter Neurosciences is one of the most popular companies on Eulerpool.

ROE Details

Decoding Jupiter Neurosciences's Return on Equity (ROE)

Jupiter Neurosciences's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Jupiter Neurosciences's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Jupiter Neurosciences's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Jupiter Neurosciences’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Jupiter Neurosciences stock

Return on Equity (ROE) of Jupiter Neurosciences is 471.92 % in 2025.

Return on Equity (ROE) of Jupiter Neurosciences changed from -58.48 % to 471.92 %, representing a -907.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Jupiter Neurosciences since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Jupiter Neurosciences with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Jupiter Neurosciences

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Jupiter Neurosciences